Integrative Physiology |
From the Institut de Recherches Servier, Suresnes, France.
Correspondence to Paul M. Vanhoutte, Institut de Recherches Internationales Servier, 6 Place des Pléiades, 92415 Courbevoie, France. E-mail vanhoutt{at}servier.fr
| Abstract |
|---|
|
|
|---|
Key Words: endothelial dysfunction modified LDL cGMP endothelial NO synthase senescence
| Introduction |
|---|
|
|
|---|
2-adrenergic
agonists, whereas those to ADP or bradykinin are
maintained.1 2 This selective dysfunction of the pertussis
toxinsensitive signaling pathway is accompanied by a morphological
heterogeneity of the regenerated
endothelial cells,3 as is also observed
with atherosclerosis and senescence.4 5 6
The present study was designed to further compare cells derived
from control and regenerated endothelium. | Materials and Methods |
|---|
|
|
|---|
Histology
Control and previously denuded coronary arteries were
immersed in cold physiological salt solution
containing (in mmol/L) CaCl2 2.5, EDTA
0.016, NaCl 118, NaHCO3 24.8,
KH2PO4 1.18, KCL 4.7,
MgSO4 1.2, and glucose 11. A ring of each artery
was fixed (4% formaldehyde). Different nonserial cross sections
(5 mm in length, 200 mm apart) were prepared from paraffin
blocks and stained with hematoxylin-eosin-safran for light
microscopy.
Primary Cultures
Endothelial cells from native and injured
coronary arteries were cultured as described.3
Cell Size
Light Microscopy
Cells on 24-well plates were fixed (ethanol), stained
(Hemacolor reagents; Merck)7 and examined with a
computerized image-analysis system (Histo Software,
Biocom).
Flow Cytometry
Cells were washed with EBSS and treated with trypsin-EDTA to
obtain a single-cell suspension. Diameter was analyzed with a
flow cytometer (EPICS XL/MCL (Beckman Coulter, Villepinte, France).
DNA Content
DNA content was determined in permeabilized
fixed cells with propidium iodide.8 Subconfluent cultures
were trypsinized, washed, fixed/permeabilized (ice-cold
70% ethanol overnight at -20°C), incubated with 50 µg/mL
propidium iodide (Sigma Chemical Co) and 100 µg/mL RNase in isotonic
phosphate buffer for 1 hour (20°C), and analyzed by flow
cytometry. Cells in the different phases of the cell cycle were
measured. Apoptotic cells were identified by reduced staining
after loss of DNA (hypodiploid or sub-G1 peak in
a DNA histogram).
Mitochondrial Alterations
Transmembrane mitochondrial potential and oxidative capacity
were measured with 3,3'-dihexylocarbocyanine iodide (40 nmol/L) and
dihydroethidium (20 µmol/L), respectively (Molecular
Probes).9 10
LDL
LDL (d=1.019 to 1.063) from plasma of healthy,
normolipidic volunteers was oxidized by exposure to 5 µmol/L
CuSO4 at 37°C for 24 hours. Oxidation was
arrested with 200 µmol/L EDTA. Oxidized LDL was dialyzed against
PBS-200 µmol/L EDTA at 4°C. The protein concentration was
determined.11 The amount of thiobarbituric
acidreactive lipid peroxides was checked using a
colorimetric assay and malondialdehyde as a standard.
Thiobarbituric acid reactivity of 24-houroxidized LDL after dialysis
was 5.1±1.1 nmol of malondialdehyde/mg of protein (starting LDL,
0.8±0.1 nmol/mg).
Uptake of Fluorescent LDL
Confluent monolayers (passage 1) were incubated with 5 µg/mL
fluorescence-conjugated acetylated LDL labeled with
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine
perchlorate (Dil; 37°C in a CO2 incubator).
Then, cells were trypsinized to obtain a single-cell suspension. The
incorporation of Dil-LDL was quantified by flow cytometry. Cells were
incubated with Dil-acetylated LDL for 4 hours or with
Dil-native LDL for 5 hours. The concentration of acetylated LDL
needed for half-maximal incorporation (EC50) was
determined using Micropharm software (LOGINSERM).
For competition studies, cells were incubated with Dil-acetylated LDL (1 µg/mL) and 50 µg/mL of native LDL, modified LDL, or polyinosinic acid (2 hours at 37°C). Coronary arteries with control or regenerated endothelium were incubated ex vivo with Dil-acetylated LDL (5 µg/mL, for 4 hours, at 37°C in a CO2 incubator). For microscopy, the coronary arteries were fixed with 4% formaldehyde and frozen. To perform flow cytometry, cells were harvested and trypsinized.
cGMP
Endothelial cells seeded in 96-well plates were
placed in HEPES-Tris buffer (20 mmol/L) containing (in
mmol/L) NaCl 140, KCl 5.4, CaCl2 2.4, and
MgSO4 0.7, including 10 µmol/L
indomethacin and 100 µmol/L isobutyl
methylxanthine. cGMP production was determined under basal
conditions and after 1 minute of stimulation with agonists under
agitation (37°C). Agonists were the following (in µmol/L):
bradykinin 0.1, serotonin 1, and A23187 1. The level of
cGMP was measured by radioimmunoassay (Amersham, Amerlex method).
Cellular density in each well was defined (Hemacolor method).
Results are expressed as fmol per million cells. Cells from control and
regenerated endothelium were studied in
parallel.
NO Synthase (NOS) Activity
After trypsinization, cells were collected in buffer containing
50 mmol/L Tris base, EGTA (100 µmol/L), DTT (100
µmol/L), and a mixture of protease inhibitors, pH 7.4 at
4°C. To obtain cell membranes, cells were sonicated (20 strokes) on
ice and centrifuged (120g for 10 minutes). The
supernatant was centrifuged at 100 000g (60
minutes). The protein content of the pellet was
measured.11
The assay was conducted at 37°C for 1 hour under agitation in a reaction mixture of (in µmol/L) [14C]arginine (11 GBq/mmol) 1.7, calmodulin 1, flavin adenine dinucleotide and flavin mononucleotide 1, and tetrahydrobiopterin 50, as well as (in mmol/L) DTT 1, NADPH 1, and CaCl2 2, with 100 µg of cell membrane protein. The assay was terminated with HClO4 (11.6 mol/L; 4°C). The mixture was centrifuged (1000g, 10 minutes). The supernatant was analyzed by HPLC. [14C]Arginine, [14C]ornithine, and [14C]citrulline were separated using a 150x4.6mm Hypersil BDS C18 column isocratically eluted at 1 mL/min with 4 mL heptafluorobutyric acid, 125 mL acetonitrile, and 900 mL water. The radioactivity of the effluent was recorded. NOS activity was expressed as citrulline formed per minute and per mg of protein.
Endothelial NOS (eNOS) Expression
For immunocytochemistry staining of eNOS, monoclonal antibodies
(20 µg/mL) recognizing particulate eNOS were applied (room
temperature) for 1 hour. Two types of secondary antibodies were used,
Alexa 488 rabbit anti-mouse (0.2 µg/mL) and
125I-labeled sheep anti-mouse (0.02 µg/mL). All
washes were performed with PBS1% BSA.
Statistical Analysis
Data are expressed as mean±SEM; n refers to the number of
animals. Statistical evaluation was performed by paired Student
t test. Multiple comparisons of kinetic curves are based on
the Newman-Keuls test. Differences were considered to be significant at
P<0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
Cell Size
In primary culture, control cells were mostly uniform in
size and displayed a cobblestone pattern (Figure 1
). Regenerated
cells were heterogenous with the presence of sparse
giant cells. Such cells incorporated Dil-acetylated LDLs and
were not stained by antibodies against anti-smooth muscle
-actin
(not shown). Flow cytometry (Figure 2
)
revealed that in control and regenerated cultures, the majority of
endothelial cells had a diameter of
11 µm.
Cells with a diameter >14.5 µm were significantly more numerous
in cultures from regenerated than those from control
endothelium. Counting of giant cells confirmed a
significant increase in the number of enlarged cells after denudation
(4.17±1.69 and 9.88±3.3 per 1000 cells for control and regenerated
cells, respectively).
|
Proliferation
The percentage of cells in S and G2/M
phases was significantly lower in cultures from regenerated than
control endothelium (11.6±0.9 versus 18.9±2.7%,
respectively). The reduction in proliferating cells was associated with
a significant increase in the sub-G1 population
relative to apoptotic cells in cultures from regenerated
endothelium (2.6±0.7% versus 1.4±0.4%).
Mitochondrial Dysfunction
An increased oxidation of dihydroethidium associated with a
decreased mitochondrial transmembrane potential was revealed by the
biparametric analysis of cultures from regenerated
cells. A greater number of cells with altered mitochondrial function
was observed in regenerated endothelial cells (Figure 3
).
|
Acetylated LDL
Cultured endothelial cells from control and
regenerated endothelium incorporated
fluorescent acetylated LDL (Figure 4
). Smooth muscle cells remained
unstained under the same conditions (not shown). The incorporation of
acetylated LDL was time and concentration dependent (Figure 5
). It was significantly lower for
control than for regenerated cells (Figure 5
). The
EC50 was similar for the 2 populations of cells
(8 to 10 µg/mL). No significant difference in native LDL
incorporation was detected between control and regenerated cells
(Figure 5
).
|
|
Addition of a 50-fold excess of native LDL did not abolish the uptake of Dil-acetylated LDL, whereas nonlabeled acetylated LDL or polyinosinic acid had the same effect (95% and 99%, respectively). The nonspecific staining was comparable between control and regenerated cells (3.6±0.9 and 4.8±1.6%, respectively).
An excess of oxidized LDL partially inhibited acetylated LDL incorporation in control and regenerated cells. The remaining acetylated LDL uptake after incubation with oxidized LDL was identical in cultures from control and regenerated endothelium. The increased uptake of acetylated LDL observed in cultures from regenerated endothelium was abolished by oxidized LDL.
Incorporation of Acetylated LDL Ex Vivo
Sections of artery with regenerated (Figure 6
) or native (not shown)
endothelium demonstrated incorporation of
acetylated LDL in endothelial cells, whereas
the underlying smooth muscle cells remained unstained. Flow cytometry
revealed that regenerated endothelium exhibited a
significantly greater incorporation of acetylated LDL than of
native endothelium (Figure 6
).
|
cGMP
N-Nitro-L arginine (NLA;
10 µmol/L) inhibited basal and bradykinin-induced cGMP
production in endothelial cells (basal,
2273±258, and with NLA, 587±64 fmol/million cells; stimulated,
4360±134, and with NLA, 627±127 fmol/million cells).
Oxadiazoloquinoxalin (ODQ, 1 µmol/L), a soluble
guanylate cyclase inhibitor, also inhibited
basal and bradykinin-stimulated production of cGMP in
endothelial cells (basal, 1203±328, and with ODQ,
458±69 fmol/million cells; stimulated, 4095±1560, and with ODQ,
638±128 fmol/million cells; n=6). The basal cGMP production
was decreased significantly (by 55%) in cultures from regenerated
endothelium. cGMP production induced by
bradykinin (0.1 µmol/L), serotonin (1
µmol/L), and calcium ionophore (A23187, 1 µmol/L) was also
reduced (Table
).
|
NOS Activity
In cell membranes from both control and regenerated
endothelium, the citrulline production was
abolished by LNA (10 µmol/L) without formation of ornithine
(Figure 7
). The NOS activity
(Vmax) and the Michaelis constant
(Km) of membranes from native
endothelial cells were 1.12±0.10 pmol/minxmg
protein1 and 0.61± 0.06 µmol/L (n=4),
respectively. The basal NOS activity of membranes from regenerated
endothelial cells was significantly lower than that
measured in membranes of native endothelial cells
(Figure 7
).
|
eNOS Expression
The nonspecific fluorescence represented
<14% whatever the origin of the cells, indicating the specificity of
the staining. The fluorescence values for control and
regenerated endothelial cells were not different
(16.5±1.1 and 16.8±1.2 arbitrary units; n=4). The flow cytometric
biparametric analysis, comparing the intensity of the
fluorescence as a function of cell size, did not show
differences in eNOS expression between normal and large
endothelial cells.
Likewise, no significant difference in eNOS expression was found between control and regenerated endothelial cells using 125I-labeled secondary antibodies (94 090±19 541 and 79 073±14 555 cpm/million cells, respectively; n=9).
| Discussion |
|---|
|
|
|---|
The present findings suggest that cells from regenerated endothelium have a reduced capacity to proliferate. In vitro, increase in cell volume and decline in proliferative capacity characterize endothelium that becomes senescent after a large number of subcultures.6 Hence, the numerous endothelial cell doublings that the cells undergo in vivo to repopulate the luminal surface of the artery after balloon injury could be sufficient to induce an altered phenotype of cells. In mammals, cells damaged by age are eliminated by apoptosis. The presence of apoptotic events in control and regenerated endothelium was evaluated by measuring partial loss of nuclear DNA content8 and mitochondrial dysfunction that precedes nuclear DNA alteration.9 13 14 15 Apoptotic cells sequentially exhibit a reduction in mitochondrial transmembrane potential and then an increase in production of reactive oxygen species. In the present study, the number of cells with nuclear and mitochondrial alterations increased in regenerated compared with control cultures. This decrease in mitochondrial transmembrane potential is often associated with an increased ability of cells from regenerated endothelium to oxidize dihydroethidium, indicating a modification of their redox homeostasis, which could involve an increased production of reactive oxygen species. Human senescent endothelial cells maintained in culture for up to 5 passages display a greater rate of apoptosis than younger cells.16 Thus, in the present study, the increased number of apoptotic cells in regenerated cultures may be another sign of senescence. This tendency to increased apoptosis associated with a reduced proliferative potential may alter the integrity of the regenerated endothelial lining in the arterial wall. This could contribute to the progression of the impairment of endothelium-dependent relaxation after balloon injury.2 17
A major finding of the present study is that all cells from regenerated endothelium in porcine coronary arteries exhibit an increased uptake of modified LDL. The global shift in fluorescence intensity of cells from regenerated endothelium demonstrates that both normal and enlarged cells present an increased ability to incorporate the modified LDL. In parallel, ex vivo arteries with regenerated endothelium exhibited a greater ability to incorporate modified LDL than those with native endothelium. Thus, the increased uptake of modified LDL was not due to the culture conditions but to an alteration of the phenotype of cells during the regeneration process.
The incorporation of acetylated LDL was saturable, with an identical apparent EC50 in both types of cells. The maximal uptake was 2-fold higher in cultures from regenerated than those from native endothelium. The remaining nonspecific staining was comparable, demonstrating that the greater fluorescence intensity of regenerated cells is not due to a higher nonspecific staining. These findings suggest an increase in acetylated LDL (scavenger) receptor density in cells from denuded blood vessels. These receptors are present constitutively on endothelial cells and exhibit characteristic ligand specificity different from receptors for native LDL.18 19 The modifications of LDL that convert it into a high-affinity ligand for the scavenger receptors include acetylation and oxidation. These binding sites share the property of being completely inhibited by polyinosinic acid but not by native LDL.18 19 This is confirmed by the competition experiments performed in the present study in cells from both control and regenerated endothelium. Only a partial competition of acetylated LDL uptake by oxidized LDL was observed. Nonreciprocal cross-competition between modified lipoproteins does not necessarily imply the presence of receptors specific only for acetylated LDL rather than receptors that recognize acetylated and oxidized LDL.18 Different binding sites on the same receptor or the extent of oxidation of the modified LDL could be involved.20 21 22 The increased degree of competition of acetylated LDL uptake with oxidized LDL in cells from regenerated endothelium demonstrates an increased capacity of such cells to take up oxidized LDL through a scavenger receptor that recognizes both oxidized and acetylated LDL.
As in macrophages,23 the uptake of acetylated LDL is increased in endothelial cells from older rats.24 In bovine aortic endothelial cells, growth cessation acts as a signal for upregulation of scavenger receptor activity.25 Certain inflammatory cytokines upregulate the expression of receptors for modified LDL in macrophages.26 In the present study, the persisting increased uptake of acetylated LDL in cells from regenerated endothelium separated from components of regenerated lesions implies an intrinsic (genetic) modification of these cells. The numerous cell doublings could be implicated, given that an increased uptake of acetylated LDL has been observed after several passages in vitro of endothelial cells from control porcine coronary arteries (data not shown).
Arteries exposed to modified LDL exhibit impaired endothelium-dependent responses, a phenomenon closely resembling that observed in atherosclerotic arteries.27 Oxidized LDL or its lipid constituents induce a selective alteration of endothelium-dependent relaxations similar to that observed 28 days after denudation.28 29 30 31 32 Transendothelial cholesterol transport takes place at caveolae, where endothelial signal transductions, such as G proteins and NOS, are situated.33 This colocalization in the plasma membrane may facilitate the interaction of these transduction signals. A second major finding was that the production of NO is reduced in cultures from regenerated endothelium. Indeed, the formation of NO measured as increases in intracellular cGMP under basal conditions or that induced by various agonists was decreased. Likewise, the activity of eNOS, estimated by measuring the citrulline formed during the oxidation of arginine, demonstrated that indeed the enzyme activity is decreased in cultures from regenerated endothelium, which then explains a reduced production of cGMP. However, this abnormal enzyme activity cannot be explained by a decrease of eNOS expression in cultures from previously injured coronary arteries.
In arteries with regenerated endothelium, the relaxation in response to serotonin is impaired severely, whereas that due to bradykinin is mildly to moderately reduced and that due to the calcium ionophore remains unchanged2 3 ; this appears to be related to the ability of these agonists to stimulate the production of cGMP in the regenerated endothelium. Contrary to the relaxations induced by both bradykinin and the calcium ionophore for which the decreased production of NO can be compensated by the release of endothelium-derived hyperpolarizing factor,34 35 serotonin exclusively stimulated NO production and so fails to induce relaxation of coronary arteries with regenerated endothelium. The present findings permit us to propose an explanation for the endothelial dysfunction in which the pertussis toxinsensitive G protein pathway is altered first.31 36 After balloon injury of the vascular wall, the endothelial cells that repopulate the denuded area exhibit characteristics of senescent cells with an increase in the uptake of modified LDL. It is tempting to propose that this phenomenon modifies the redox homeostasis of the endothelial cells and alters the function of G proteins and of the NOS involved in the endothelium-dependent relaxations.
| Acknowledgments |
|---|
Received January 26, 2000; accepted February 16, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. M. Vanhoutte Arginine and Arginase: Endothelial NO Synthase Double Crossed? Circ. Res., April 25, 2008; 102(8): 866 - 868. [Full Text] [PDF] |
||||
![]() |
M. Y.K. Lee, H.-F. Tse, C.-W. Siu, S.-G. Zhu, R. Y.K. Man, and P. M. Vanhoutte Genomic Changes in Regenerated Porcine Coronary Arterial Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2443 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lansiaux, S. Leonce, L. Kraus-Berthier, C. Bal-Mahieu, R. Mazinghien, S. Didier, M.-H. David-Cordonnier, P. Hautefaye, G. Lavielle, C. Bailly, et al. Novel Stable Camptothecin Derivatives Replacing the E-Ring Lactone by a Ketone Function Are Potent Inhibitors of Topoisomerase I and Promising Antitumor Drugs Mol. Pharmacol., August 1, 2007; 72(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Hinagata, M. Kakutani, T. Fujii, T. Naruko, N. Inoue, Y. Fujita, J. L. Mehta, M. Ueda, and T. Sawamura Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model Cardiovasc Res, January 1, 2006; 69(1): 263 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes, I. Fleming, and R. Busse Endothelial aging Cardiovasc Res, May 1, 2005; 66(2): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Smirnova, T. Sawamura, and M. S. Goligorsky Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency Am J Physiol Renal Physiol, July 1, 2004; 287(1): F25 - F32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Haendeler, J. Hoffmann, J. F. Diehl, M. Vasa, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells Circ. Res., April 2, 2004; 94(6): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayranpaa, J. Simpanen, M. W. Hess, K. Werkkala, and P. T. Kovanen Arterial endothelial denudation by intraluminal use of papaverine-NaCl solution in coronary bypass surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Strotmann, J. Bauersachs, D. Fraccarollo, M. Kirchengast, P. A. Schnabel, J. Sykora, G. Ertl, and W. Voelker Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2356 - H2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Vanhoutte Ageing and endothelial dysfunction Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A8 - A17. [Abstract] [PDF] |
||||
![]() |
E. A. Jaimes, C. Sweeney, and L. Raij Effects of the Reactive Oxygen Species Hydrogen Peroxide and Hypochlorite on Endothelial Nitric Oxide Production Hypertension, October 1, 2001; 38(4): 877 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohler, S. Brakemeier, M. Kuhn, C. Behrens, R. Real, C. Degenhardt, H.-D. Orzechowski, A. R. Pries, M. Paul, and J. Hoyer Impaired Hyperpolarization in Regenerated Endothelium After Balloon Catheter Injury Circ. Res., July 20, 2001; 89(2): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hoffmann, J. Haendeler, A. Aicher, L. Rossig, M. Vasa, A. M. Zeiher, and S. Dimmeler Aging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli: Important Role of Nitric Oxide Circ. Res., October 12, 2001; 89(8): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||